|Videos|January 25, 2021
CAR T-Cell Therapy for the Management of Multiple Myeloma
Oncologists explore the opportunity of CAR T-cell therapy for the treatment of relapsed/refractory multiple myeloma.
Advertisement
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Advertisement
Related Articles
Latest CME
Advertisement
Advertisement
Trending on AJMC
1
West Coast Health Alliance Releases First Vaccine Guidelines, Aiming to Replace CDC Recommendations
2
Metabolic Issues More Common in Patients With HIV
3
Iron Dysregulation Linked to MS Progression, Review Finds
4
Barriers to Gender-Affirming Surgery Persist Despite High Satisfaction Rate
5